Literature DB >> 15292971

Effectiveness and prognostic factors of radiotherapy for painful plantar heel spurs.

Oliver Schneider1, Christoph A Stückle, Elisabeth Bosch, Corinna Gott, Irenäus A Adamietz.   

Abstract

BACKGROUND AND
PURPOSE: The efficacy of radiation treatment (RT) for plantar heel pain has been reported repeatedly. Yet, the results referring to the pain relief rate, to long-term effects and prognostic factors are not consistent. In this paper, the effectiveness (pain relief rate and long-term results) and prognostic factors of RT for plantar heel pain have been investigated. PATIENTS AND METHODS: From January 2000 to October 2000, 62 patients (73 heels) with painful plantar heel spurs and a minimum pain history of 3 months were treated and evaluated in a prospective study. Mean age was 54 years (range 28-84 years). All patients were treated with a total dose of 5 Gy in seven fractions (= one series), given twice a week at a single-dose sequence of 0.25-0.25-0.5-1.0-1.0-1.0-1.0 Gy (10-MV photons, source-skin distance [SSD] 100 cm, direct portal, field size 12 x 17 cm). The mean duration of heel pain before RT was 26 weeks (= 6.5 months; range 3-120 months). By means of a visual analog scale (VAS) the patients had to self-assess the quantity of their heel pain once before, three times during and four times after RT at a longterm median follow-up of 28 and 40 months. Additionally, the patients had to assess their mechanical heel stress extent during RT. Effectiveness was estimated according to the patients' judgment of pain reduction.
RESULTS: A significant reduction of heel pain extent measured by VAS has been observed already during the RT series (before RT: 6.3 +/- 1.5 vs. 3.8 +/- 2.1 at the end of RT; p < 0.001). 6 weeks after RT (FU 1) pain reduction (> 20%) was achieved in 60 heels (82.3%; n = 73), in 64 heels (91.4%; n = 70) after a mean follow-up of 28 months (FU 2), and in 61 heels (89.7%; n = 68) after a mean follow-up of 40 months (FU 3), respectively. Sufficient pain relief (> 80% compared to initial extent) was observed in 18/73 heels (24.6%) at FU 1 (FU 2: 42/70; 60.0%; FU 3: 37/68; 54.4%), including 13/73 heels (17.8%) with complete pain relief (FU 2: 39/70; 55.7%; FU 3: 36/68; 52.9%). Partial improvement (50-80% pain reduction) was observed in 27/73 heels (37.0%) at FU 1 (FU 2: 14/70; 20.0%; FU 3: 15/68; 22.1%), and minor partial improvement (20-50% pain reduction) in 15/73 heels (20.5%) at FU 1 (FU 2: 8/70; 11.4%; FU 3: 9/68; 13.2%), respectively. No change was seen in 13/73 heels (17.8%) at FU 1 (FU 2: 6/70; 8.6%; FU 3: 7/68; 10.3%). Older patients (p = 0.04) and patients who avoided heel stress during the period of RT (p < 0.01) demonstrated a better short-term response (FU 1); both effects were lost 28 and 40 months after RT. Moreover, significant differences in the extent of heel pain reduction by RT were observed in dependence on previous pain duration (at FU 2-3).
CONCLUSION: The results confirm the high efficacy of RT in painful plantar spur and add new aspects to formerly published data concerning the time course of changes in heel pain reduction. Pain relief can be expected during and shortly after RT. In addition, the initial success can be transformed into effective long-term results > 2 years after RT; however, further improvement is not to be expected. As a new prognostic factor, the reduction of mechanical heel stress during RT may ameliorate the short-term results, whereas short heel pain history improves the long-term results. Especially for older patients, RT should be taken into consideration as primary treatment.

Entities:  

Mesh:

Year:  2004        PMID: 15292971     DOI: 10.1007/s00066-004-1204-7

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  8 in total

1.  Re-irradiation for painful heel spur syndrome. Retrospective analysis of 101 heels.

Authors:  M G Hautmann; U Neumaier; O Kölbl
Journal:  Strahlenther Onkol       Date:  2014-01-24       Impact factor: 3.621

2.  [Plantar fasciitis and radiotherapy. Clinical and radiobiological treatment results].

Authors:  O Micke; M H Seeegenschmiedt; R Mücke; A de Vries; U Schäfer; N Willich
Journal:  Orthopade       Date:  2005-06       Impact factor: 1.087

3.  Retrospective evaluation of the effectiveness of radiotherapy in patients with plantar fascitis (heel spurs).

Authors:  Piotr Kędzierawski; Rafał Stando; Paweł Macek
Journal:  Rep Pract Oncol Radiother       Date:  2017-04-21

4.  Radiotherapy for calcaneodynia. Results of a single center prospective randomized dose optimization trial.

Authors:  O J Ott; C Jeremias; U S Gaipl; B Frey; M Schmidt; R Fietkau
Journal:  Strahlenther Onkol       Date:  2013-02-28       Impact factor: 3.621

5.  Role of radiotherapy in the management of heel spur.

Authors:  Bora Uysal; Murat Beyzadeoglu; Omer Sager; Selcuk Demıral; Hakan Gamsız; Ferrat Dıncoglan; Mustafa Akın; Bahar Dırıcan
Journal:  Eur J Orthop Surg Traumatol       Date:  2014-05-17

6.  Long-term effect and prognostic factors of a low-dose radiotherapy of painful plantar calcaneal spurs : A retrospective unicenter study.

Authors:  Volker Rudat; Nikoleta Tontcheva; Gudrun Kutz; Tina Ojevwe Orovwighose; Erich Gebhardt
Journal:  Strahlenther Onkol       Date:  2021-01-27       Impact factor: 3.621

7.  Low-dose radiation treatment for painful plantar enthesophyte: a highly effective therapy with little side effects.

Authors:  Freddy Djiepmo; Bálint Tamaskovics; Edwin Bölke; Matthias Peiper; Jan Haussmann; Judith Neuwahl; Danny Jazmati; Kitti Maas; Livia Schmidt; Roman Gelzhäuser; Christoph Schleich; Stefanie Corradini; Klaus Orth; Martijn van Griensven; Amir Rezazadeh; Kimia Karimi; Wilfried Budach; Christiane Matuschek
Journal:  Eur J Med Res       Date:  2022-02-23       Impact factor: 2.175

Review 8.  Radiotherapy CT-based contouring atlas for non-malignant skeletal and soft tissue disorders: a practical proposal from Spanish experience.

Authors:  Beatriz Alvarez; Angel Montero; Ovidio Hernando; Raquel Ciervide; Juan Garcia; Mercedes Lopez; Mariola Garcia-Aranda; Xin Chen; Ines Flores; Emilio Sanchez; Jeannette Valero; Alejandro Prado; Rosa Alonso; Leyre Alonso; Pedro Fernandez-Leton; Carmen Rubio
Journal:  Br J Radiol       Date:  2021-08-01       Impact factor: 3.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.